JPS57183718A - Drug composition for inhibiting n-nitroso compound formation - Google Patents

Drug composition for inhibiting n-nitroso compound formation

Info

Publication number
JPS57183718A
JPS57183718A JP57070564A JP7056482A JPS57183718A JP S57183718 A JPS57183718 A JP S57183718A JP 57070564 A JP57070564 A JP 57070564A JP 7056482 A JP7056482 A JP 7056482A JP S57183718 A JPS57183718 A JP S57183718A
Authority
JP
Japan
Prior art keywords
inhibiting
drug composition
nitroso compound
compound formation
formation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57070564A
Other languages
English (en)
Japanese (ja)
Inventor
Jiyosefu Maagenzu Uiriamu
Reon Niyuumaaku Harorudo
Ranchihoodasu Shi Purabuhaakaa
Rebon Tosoonian Jiyatsuku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPS57183718A publication Critical patent/JPS57183718A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP57070564A 1981-04-29 1982-04-28 Drug composition for inhibiting n-nitroso compound formation Pending JPS57183718A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25896281A 1981-04-29 1981-04-29

Publications (1)

Publication Number Publication Date
JPS57183718A true JPS57183718A (en) 1982-11-12

Family

ID=22982879

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57070564A Pending JPS57183718A (en) 1981-04-29 1982-04-28 Drug composition for inhibiting n-nitroso compound formation

Country Status (6)

Country Link
JP (1) JPS57183718A (enrdf_load_stackoverflow)
CH (1) CH649215A5 (enrdf_load_stackoverflow)
DE (1) DE3215086A1 (enrdf_load_stackoverflow)
FR (1) FR2504802A1 (enrdf_load_stackoverflow)
GB (1) GB2097676B (enrdf_load_stackoverflow)
IT (1) IT1195924B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
EA200700388A1 (ru) 2004-08-13 2007-08-31 Бёрингер Ингельхайм Интернациональ Гмбх Композиция пеллеты пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ её изготовления и её применение
DK1781260T4 (da) 2004-08-13 2014-06-23 Boehringer Ingelheim Int Tabletformulering med forlænget frigivelse indeholdende pramipexol eller et farmaceutisk acceptabelt salt deraf, fremgangsmåde til fremstilling deraf og anvendelse deraf
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH380953A (de) * 1956-11-30 1964-08-15 Hoechst Ag Verfahren zur Herstellung von phosphorhaltigen Polyestern
IL24216A (en) * 1964-09-09 1968-11-27 Hoffmann La Roche Vitamin preparation and process for the manufacture thereof
FR1446273A (fr) * 1964-09-09 1966-07-15 Hoffmann La Roche Procédé pour la fabrication d'une préparation vitaminée
AT257330B (de) * 1964-09-09 1967-10-10 Hoffmann La Roche Verfahren zur Herstellung eines Vitaminpräparates
FR5041M (enrdf_load_stackoverflow) * 1965-10-01 1967-05-02
US3607310A (en) 1966-07-29 1971-09-21 James F Carter Jr Production of fortified sugar
NL7106929A (enrdf_load_stackoverflow) * 1970-05-20 1971-11-23
DD103056B1 (de) 1972-01-12 1980-11-26 Kurt Schuch Einrichtung zum messen von verschiebungen
CH584013A5 (enrdf_load_stackoverflow) * 1972-12-15 1977-01-31 Hoffmann La Roche
FR2244468A1 (en) * 1973-07-31 1975-04-18 Passwater Richard Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
US3950547A (en) * 1974-08-26 1976-04-13 Syntex (U.S.A.) Inc. Dietary composition and methods of preparing
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
GB2052986B (en) * 1979-07-09 1983-08-17 Graebner E B Reducing smoking urge

Also Published As

Publication number Publication date
IT1195924B (it) 1988-11-03
FR2504802A1 (fr) 1982-11-05
FR2504802B1 (enrdf_load_stackoverflow) 1985-05-10
CH649215A5 (de) 1985-05-15
IT8220999A0 (it) 1982-04-29
DE3215086A1 (de) 1982-11-18
GB2097676B (en) 1985-02-13
GB2097676A (en) 1982-11-10

Similar Documents

Publication Publication Date Title
DE3279470D1 (en) New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
IL64847A0 (en) Hexapyranose compounds,their manufacture and pharmaceutical compositions containing them
ZA825553B (en) Pharmaceutical sustained-release compositions
ZA824622B (en) Pharmaceutical compositions
JPS57200436A (en) Composition for thermoplastic formation
GB2096889B (en) Pharmaceutical composition containing 6-amino-1-hydroxyhexane-1,1-diphosphonic acid
PT75620A (en) Novel compounds
ZA825397B (en) Pharmaceutical compositions
PT75472A (en) Process for preparing novel imidazoquinazoline derivativesand pharmaceutical compositions containing the same
ZA822856B (en) Pharmaceutical compositions
ZA82652B (en) Pharmaceutical compositions
DE3273166D1 (en) Hydrocarbon compositions containing heteroaromatic nitrogen compounds
PT74377B (en) Novel compounds
GB8305175D0 (en) Substituted thiopyranopyrimidine pharmaceutical compounds
JPS57183718A (en) Drug composition for inhibiting n-nitroso compound formation
ZA818221B (en) Pharmaceutical compounds
GB8332269D0 (en) Pharmaceutical compounds
GB2055042B (en) Pharmaceutical compositions containing substituted biruets compound
JPS56139480A (en) Quinoline compound or medicinal composition containing same
SG59387G (en) Pharmaceutical compositions
ZA826479B (en) Pharmaceutical compositions
JPS57171921A (en) Anthelmintic composition
JPS57181007A (en) Local drug composition
IL65602A0 (en) Beta-lactam compounds and pharmaceutical compositions containing the same and process for the preparation thereof